BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37129607)

  • 1. Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer.
    Fan X; Huang J; Hu B; Zhou J; Chen L
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8729-8741. PubMed ID: 37129607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PP2A regulates metastasis and vasculogenic mimicry formation via PI3K/AKT/ZEB1 axis in non-small cell lung cancers.
    Zhang Y; Wang X; Li A; Guan Y; Shen P; Ni Y; Han X
    J Pharmacol Sci; 2022 Oct; 150(2):56-66. PubMed ID: 36055752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 knockdown suppresses vasculogenic mimicry of non-small cell lung cancer by modulating ZEB1-triggered EMT.
    Li W; Wu J; Jia Q; Shi Y; Li F; Zhang L; Shi F; Wang X; Wu S
    BMC Cancer; 2024 May; 24(1):633. PubMed ID: 38783271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms.
    Xia Y; Cai XY; Fan JQ; Zhang LL; Ren JH; Li ZY; Zhang RG; Zhu F; Wu G
    Int J Cancer; 2019 May; 144(9):2227-2238. PubMed ID: 30374974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxazosin inhibits vasculogenic mimicry in human non‑small cell lung cancer through inhibition of the VEGF‑A/VE‑cadherin/mTOR/MMP pathway.
    Hsu JL; Leu WJ; Hsu LC; Hsieh CH; Guh JH
    Oncol Lett; 2024 Apr; 27(4):170. PubMed ID: 38455663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baicalein suppresses vasculogenic mimicry through inhibiting RhoA/ROCK expression in lung cancer A549 cell line.
    Zhang Z; Nong L; Chen M; Gu X; Zhao W; Liu M; Cheng W
    Acta Biochim Biophys Sin (Shanghai); 2020 Sep; 52(9):1007-1015. PubMed ID: 32672788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
    Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X
    Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent kinase 5 controls vasculogenic mimicry formation in non-small cell lung cancer via the FAK-AKT signaling pathway.
    Zhou X; Gu R; Han X; Wu G; Liu J
    Biochem Biophys Res Commun; 2017 Oct; 492(3):447-452. PubMed ID: 28842255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells.
    Yeo C; Han DS; Lee HJ; Lee EO
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZLDI-8 suppresses angiogenesis and vasculogenic mimicry in drug-resistant NSCLC in vitro and in vivo.
    Lu H; Wu C; Jiang XW; Zhao Q
    Lung Cancer; 2023 Aug; 182():107279. PubMed ID: 37364397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells.
    Yeo C; Lee HJ; Lee EO
    Life Sci; 2019 Mar; 221():267-273. PubMed ID: 30797819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD276 Promotes Vasculogenic Mimicry Formation in Hepatocellular Carcinoma via the PI3K/AKT/MMPs Pathway.
    Cheng R; Wang B; Cai XR; Chen ZS; Du Q; Zhou LY; Ye JM; Chen YL
    Onco Targets Ther; 2020; 13():11485-11498. PubMed ID: 33204103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype.
    Yao L; Zhang D; Zhao X; Sun B; Liu Y; Gu Q; Zhang Y; Zhao X; Che N; Zheng Y; Liu F; Wang Y; Meng J
    J Cell Mol Med; 2016 Sep; 20(9):1673-85. PubMed ID: 27240974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway.
    Han J; Hu J; Sun F; Bian H; Tang B; Fang X
    Mol Cell Biochem; 2021 Feb; 476(2):689-698. PubMed ID: 33125611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesis of non-small cell lung cancer via the Akt pathway.
    Qi L; Zhu F; Li SH; Si LB; Hu LK; Tian H
    PLoS One; 2014; 9(8):e106032. PubMed ID: 25162518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
    Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
    J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.
    Zhang JT; Sun W; Zhang WZ; Ge CY; Liu ZY; Zhao ZM; Lu XS; Fan YZ
    BMC Cancer; 2014 Mar; 14():193. PubMed ID: 24628713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.
    Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH
    World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
    He L; Zhang E; Shi J; Li X; Zhou K; Zhang Q; Le AD; Tang X
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):713-25. PubMed ID: 23292117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.